PA
HSTO

Perceptive Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Perceptive Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed -$2K – 183
2015
Q3 		$2K Sell
2
-498
-100% -$454K ﹤0.01% 158
2015
Q2 		$515K Buy
+500
New +$586K 0.03% 129

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Perceptive Advisors's HSTO Position: Q4 2015 in Review

Perceptive Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q4 2015, closing a stake of 2 shares — an estimated $2K sold.

Perceptive Advisors first reported a position in HSTO in Q2 2015 and held it in 2 quarters. The position peaked at $515K in Q2 2015. 43 funds tracked by Wall St. Rank hold HSTO as of Q4 2015.

  • Perceptive Advisors reported no remaining Histogen Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Perceptive Advisors sold 2 Histogen Inc. Common Stock shares in Q4 2015, an estimated $2K.
  • Perceptive Advisors first reported a position in Histogen Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • Perceptive Advisors's Histogen Inc. Common Stock position peaked at $515K in Q2 2015.
  • 43 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2015.

Based on Perceptive Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.